Literature DB >> 3251033

Competing pathways in drug metabolism. II. An identical, anterior enzymic distribution for 2- and 5-sulfoconjugation and a posterior localization for 5-glucuronidation of gentisamide in the rat liver.

M E Morris1, V Yuen, K S Pang.   

Abstract

Gentisamide (2,5-dihydroxybenzamide, GAM), a substrate that forms two monosulfates at the 2 and 5 positions (GAM-2S and GAM-5S) and a monoglucuronide at the 5 position (GAM-5G), was delivered at 8 or 80 microM by normal (N) and retrograde (R) flows to the once-through rat liver preparation. At the lower (8 microM) input concentration, ratios of conjugate formation rate, GAM-5S/GAM-5G and GAM-2S/GAM-5G, were decreased significantly (4.01 +/- 1.42 to 2.93 +/- 0.99, and 1.13 +/- 0.65 to 0.66 +/- 0.41, respectively) whereas a small but significant increase in the steady-state extraction ratio, E (0.89 +/- 0.029 to 0.94 +/- 0.016), was observed upon changing the flow direction from N to R. At the higher input GAM concentration (80 microM), conjugate formation rate ratios were relatively constant for GAM-5S/GAM-5G (1.18 +/- 0.08 to 1.11 +/- 0.12) and GAM-2S/GAM-5G (0.33 +/- 0.05 to 0.31 +/- 0.05) upon changing flow direction from N to R, despite a slight increase in E from 0.87 +/- 0.023 to 0.91 +/- 0.016 was observed. These results suggest that the sulfotransferase activities responsible for 2- and 5-sulfoconjugations are identically distributed and localized anterior to 5-glucuronidation activities during a normal flow of substrate into the rat liver (entering the portal vein and exiting the hepatic vein), and that the presence of uneven distribution of conjugation activities is discriminated only at the lower input drug concentration. At high concentration (greater than Km for all systems), saturation of all pathways occurs, and other anteriorly/identically distributed competing pathways would fail to perturb downstream intrahepatic drug concentrations and the resultant conjugation rates. The lack of change in metabolic profiles renders the condition unsuitable for examination of uneven distribution of enzymes in the liver. These observations were generally predicted by theoretical enzymic models of consistent distribution patterns. Because 2- and 5-sulfation were mediated by systems of similar Km but different Vmax values, two possibilities, the same isozyme of sulfotransferase being involved in the formation of two enzyme-substrate complexes to form two distinctly different products or two isozymes of sulfotransferases of identical distribution, were discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3251033     DOI: 10.1007/bf01062015

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  34 in total

1.  Subdivision of hexagonal liver lobules into a structural and functional unit; role in hepatic physiology and pathology.

Authors:  A M RAPPAPORT; Z J BOROWY; W M LOUGHEED; W N LOTTO
Journal:  Anat Rec       Date:  1954-05

2.  Competing pathways in drug metabolism. I. Effect of input concentration on the conjugation of gentisamide in the once-through in situ perfused rat liver preparation.

Authors:  M E Morris; V Yuen; B K Tang; K S Pang
Journal:  J Pharmacol Exp Ther       Date:  1988-05       Impact factor: 4.030

3.  Hepatocytes of Zones 1 and 3 conjugate sulfobromophthalein with glutathione.

Authors:  E H Chen; J J Gumucio; N H Ho; D L Gumucio
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

Review 4.  Functional hepatocellular heterogeneity.

Authors:  K Jungermann; N Katz
Journal:  Hepatology       Date:  1982 May-Jun       Impact factor: 17.425

Review 5.  Functional implications of liver cell heterogeneity.

Authors:  J J Gumucio; D L Miller
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

6.  Glucuronidation of 7-hydroxycoumarin in periportal and pericentral regions of the liver lobule.

Authors:  J G Conway; F C Kauffman; T Tsukada; R G Thurman
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

7.  An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

Authors:  K S Pang; J A Terrell; S D Nelson; K F Feuer; M J Clements; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

8.  Acinar heterogeneity in hepatic transport of dibromosulfophthalein and ouabain studied by autoradiography, normal and retrograde perfusions and computer simulation.

Authors:  G M Groothuis; K P Keulemans; M J Hardonk; D K Meijer
Journal:  Biochem Pharmacol       Date:  1983-10-15       Impact factor: 5.858

9.  Immunohistochemical localization of glutathione S-transferases in livers of untreated rats.

Authors:  J A Redick; W B Jakoby; J Baron
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

10.  Gluconeogenesis in the perfused rat liver.

Authors:  R Hems; B D Ross; M N Berry; H A Krebs
Journal:  Biochem J       Date:  1966-11       Impact factor: 3.857

View more
  4 in total

1.  Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.

Authors:  S B Hansel; M E Morris
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

2.  Membrane transport in hepatic clearance of drugs. II: Zonal distribution patterns of concentration-dependent transport and elimination processes.

Authors:  Y Kwon; M E Morris
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  Hepatic modeling of metabolite kinetics in sequential and parallel pathways: salicylamide and gentisamide metabolism in perfused rat liver.

Authors:  X Xu; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

4.  Nonlinear protein binding and enzyme heterogeneity: effects on hepatic drug removal.

Authors:  X Xu; P Selick; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1993-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.